Radius Health Inc - Company Profile
Powered by 
All the data and insights you need on Radius Health Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Radius Health Inc Strategy Report
- Understand Radius Health Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Radius Health Inc (Radius Health), formerly NuVios Inc, is a biopharmaceutical company that develops and markets novel medicines for bone health, and endocrine diseases. The company’s marketed product includes abaloparatide injection, which is indicated for the treatment of postmenopausal women with osteoporosis. Its pipeline encompasses abaloparatide subcutaneous injection (SC) for high risk of fracture in men with osteoporosis; abaloparatide transdermal (TD) patch for postmenopausal women with osteoporosis. Radius Health is headquartered in Boston, Massachusetts, the US.
Headquarters
United States of America
Address
22 Boston Wharf Road, 7th Floor, Massachusetts, 02210
Website
www.radiuspharm.com
Telephone
1 617 5514000
Industry
Pharmaceuticals and Healthcare
Radius Health Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Abaloparatide Injection | TYMLOS |
| BINOSTO | |
| Radius |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In September, the company announced an exclusive licensing agreement to EffRx Pharmaceuticals S.A. for BINOSTO in the US markets. |
| 2023 | Contracts/Agreements | In August, the company announced royalty purchase agreement with DRI Healthcare to sell a portion of its royalty and commercial interests for US$140 million. |
| 2022 | New Product Approvals | In December, the company received US FDA approval for TYMLOS to increase bone density in men with Osteoporosis. |
Competitor Comparison
| Key Parameters | Radius Health Inc | Novartis AG | AstraZeneca Plc | Eli Lilly and Co | Amgen Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | Switzerland | United Kingdom | United States of America | United States of America |
| City | Boston | Basel | Cambridge | Indianapolis | Thousand Oaks |
| State/Province | Massachusetts | - | England | Indiana | California |
| No. of Employees | - | 76,057 | 89,900 | 43,000 | 26,700 |
| Entity Type | Private | Public | Public | Public | Public |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Scott Briggs | Director; Chief Executive Officer | Executive Board | - | - |
| Bethany Senseing | Chief Financial Officer | Senior Management | 2023 | - |
| Chhaya Shah | Chief Business Officer | Senior Management | - | - |
| Ed Cinca | Chief Commercial Officer | Senior Management | - | - |
| Al Medwar | Senior Vice President - Business and Corporate Development | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward